Marking axillary nodes with 4% carbon microparticle suspension before neoadjuvant chemotherapy improves sentinel node identification rate and axillary staging

2020 ◽  
Vol 122 (2) ◽  
pp. 164-169
Author(s):  
Cleverton Cesar Spautz ◽  
Eduardo Schunemann Junior ◽  
Lucas Roskamp Budel ◽  
Tereza Cristina Santos Cavalcanti ◽  
Maria Helena Louveira ◽  
...  
Keyword(s):  
Neoadjuvant Chemotherapy ◽  
Sentinel Node ◽  
Axillary Staging ◽  
Identification Rate ◽  
Axillary Nodes ◽  
Sentinel Node Identification

High positive sentinel node identification rate by EORTC melanoma group protocol

2006 ◽  
Vol 42 (3) ◽  
pp. 372-380 ◽  
Author(s):  
A.C.J. van Akkooi ◽  
J.H.W. de Wilt ◽  
C. Verhoef ◽  
W.J. Graveland ◽  
A.N. van Geel ◽  
...  
Keyword(s):  
Sentinel Node ◽  
Positive Sentinel Node ◽  
Identification Rate ◽  
Sentinel Node Identification

Sentinel Lymph Node Surgery for Staging of Breast Carcinoma in Patients with Lymphoproliferative Disease

2010 ◽  
Vol 76 (12) ◽  
pp. 1423-1425 ◽  
Author(s):  
Benzon M. Dy ◽  
Carol A. Reynolds ◽  
Dietlind L. Wahner-Roedler ◽  
Judy C. Boughey
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Breast Carcinoma ◽  
Sentinel Node ◽  
Primary Breast Cancer ◽  
Lymphoproliferative Disease ◽  
Axillary Staging ◽  
Identification Rate

There are few reports confirming the validity of sentinel lymph biopsy in patients with a background of lymphoproliferative disease. We reviewed nine cases of women who underwent sentinel lymph node (SLN) surgery for staging of primary breast cancer with a diagnosis of lymphoproliferative disease. SLN identification rate was 100 per cent with a background of lymphoma in the sentinel node in eight of the nine patients. With a mean follow-up of 37 months, there have been no axillary recurrences in any of these patients. These cases illustrate that SLN staging is feasible and provides axillary staging information in women with breast cancer despite synchronous lymphoproliferative disease.

scholarly journals Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial

2010 ◽  
Vol 17 (7) ◽  
pp. 1854-1861 ◽  
Author(s):  
Marieke E. Straver ◽  
Philip Meijnen ◽  
Geertjan van Tienhoven ◽  
Cornelis J. H. van de Velde ◽  
Robert E. Mansel ◽  
...  
Keyword(s):  
Sentinel Node ◽  
Nodal Involvement ◽  
Identification Rate ◽  
Sentinel Node Identification

Lymphatic Mapping and Sentinel Node Identification for Colorectal Cancer

Swiss Surgery ◽  
2001 ◽  
Vol 7 (6) ◽  
pp. 252-255 ◽  
Author(s):  
Ota ◽  
Lin
Keyword(s):  
Sentinel Node ◽  
Lymphatic Mapping ◽  
Primary Treatment ◽  
Stage Iii ◽  
Nodal Disease ◽  
Node Negative ◽  
Intraoperative Procedures ◽  
Sentinel Node Identification ◽  
Node Metastases ◽  
Molecular Assessment

The primary treatment of resectable CRC is surgical resection. Postoperative adjuvant therapies are recommended when lymph node metastases are found (stage III). There is evidence that about 20% of node negative CRC cases (stage II) are understaged, i.e., they are actually node positive (stage III). New intraoperative procedures (lymphatic mapping and sentinel node identification) that are able to detect occult macro- and micrometastases. Molecular assessment of nodal disease should improve the current staging criteria for colon cancer and could influence recommendation for adjuvant treatment.

Sentinel node biopsy in breast cancer

2004 ◽  
Vol 43 (01) ◽  
pp. 4-9 ◽  
Author(s):  
A. Bembenek ◽  
H. Büchels ◽  
T. Decker ◽  
J. Dunst ◽  
U. Müllerleile ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
German Society ◽  
Consensus Conference ◽  
Consensus Meeting ◽  
Axillary Staging ◽  
International Consensus ◽  
Node Biopsy ◽  
Complete Lymph Node Dissection

SummaryThe international consensus conference from St. Gallen concerning the treatment of early breast cancer concluded in 2003, that sentinel node biopsy was now accepted as method allowing axillary staging in breast cancer. This procedure may avoid complete lymph node dissection in appropriate cases. Since numerous questions associated with the technique are still not defined and the procedure itself is not yet standardized, the German Society of Senology defined the conditions for the routine clinical use of sentinel node biopsy in an interdisciplinary consensus meeting.

The impact of superficial injections of radiocolloids and dynamic lymphoscintigraphy on sentinel node identification in oral cavity cancer: a same-day protocol

2008 ◽  
Vol 29 (4) ◽  
pp. 318-322 ◽  
Author(s):  
Girolamo Tartaglione ◽  
Maurizio G. Vigili ◽  
Siavash Rahimi ◽  
Alessandra Celebrini ◽  
Marco Pagan ◽  
...  
Keyword(s):  
Oral Cavity ◽  
Sentinel Node ◽  
Oral Cavity Cancer ◽  
Sentinel Node Identification ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document